Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v3-EN
Language English English
Date Updated 2018-04-04 2017-07-19
Drug Identification Number 01901915 01901915
Brand name LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LIDOCAINE HYDROCHLORIDE EPINEPHRINE LIDOCAINE HYDROCHLORIDE EPINEPHRINE
Strength(s) 20MG 10MCG 20MG 10MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 25x20mL VIAL/AMPOULE VIAL/AMPOULE
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-16 2017-05-16
Estimated end date 2017-12-31
Actual end date 2018-04-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments ​Please note that the other generic and brand products are available as per Health Canada Drug shortage database.
Health Canada comments